Potassium Carbonate → 3-Chloro-4-[(3-pyridazin-4-ylbiphenyl-4-yl)oxy]-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide
반응식
[N:1]1[CH:6]=[CH:5][C:4]([C:7]2[CH:8]=[C:9]([C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=3)[CH:10]=[CH:11][C:12]=2[OH:13])=[CH:3][N:2]=1.[Cl:20][C:21]1[CH:22]=[C:23]([S:28]([N:31](CC2C=CC(OC)=CC=2OC)[C:32]2[S:33][CH:34]=[N:35][N:36]=2)(=[O:30])=[O:29])[CH:24]=[CH:25][C:26]=1F.C(=O)([O-])[O-].[K+].[K+]>CS(C)=O>[Cl:20][C:21]1[CH:22]=[C:23]([S:28]([NH:31][C:32]2[S:33][CH:34]=[N:35][N:36]=2)(=[O:29])=[O:30])[CH:24]=[CH:25][C:26]=1[O:13][C:12]1[CH:11]=[CH:10][C:9]([C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)=[CH:8][C:7]=1[C:4]1[CH:5]=[CH:6][N:1]=[N:2][CH:3]=1참가 물질
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
3-Pyridazin-4-ylbiphenyl-4-ol (Preparation 4, 40 mg, 0.16 mmol) and 3-chloro-N-(2,4-dimethoxybenzyl)-4-fluoro-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide (Preparation 17, 72 mg, 0.16 mmol) were dissolved in dimethylsulfoxide (2 mL). Potassium carbonate (67 mg, 0.5 mmol) was added and the reaction stirred at room temperature for 16 hours. The crude material was partitioned between ethyl acetate (20 mL) and water (20 mL), the organic layer separated, concentrated in vacuo, dissolved in trifluoroacetic acid (1 mL) and the solution stirred for 16 hours at room temperature. The reaction was then concentrated in vacuo and purified by silica gel column chromatography (ISCO™, 12 g silica, 50-100% ethyl acetate in heptane gradient elution). The appropriate fractions were combined and concentrated in vacuo to afford the title compound as a white solid (41 mg, 49%).
후처리
- customThe crude material was partitioned between ethyl acetate (20 mL) and water (20 mL)
- customthe organic layer separated
- concentrationconcentrated in vacuo
- dissolutiondissolved in trifluoroacetic acid (1 mL)
- stirringthe solution stirred for 16 hours at room temperature
- concentrationThe reaction was then concentrated in vacuo
- custompurified by silica gel column chromatography (ISCO™, 12 g silica, 50-100% ethyl acetate in heptane gradient elution)
- concentrationconcentrated in vacuo
출처 및 근거
- ORD 기록
- ord-3b00a45166bc44c28630109aae7411d3
- 출처 데이터셋
- uspto-grants-2014_07
- 특허 번호
- US08772293B2
반응 노트
불러오는 중…